.png){kind=icon}
返回
Is Structure-Based Drug Design Ready for Selectivity Optimization?
.png){kind=icon}
OA
AI
DOI：10.1021/acs.jcim.0c00815.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Alchemical free-energy calculations are now widely used to drive or maintain potency in small-molecule lead optimization with a roughly 1 kcal/mol accuracy. Despite this, the potential to use free-energy calculations to drive optimization of compound selectivity among two similar targets has been relatively unexplored in published studies. In the most optimistic scenario, the similarity of binding sites might lead to a fortuitous cancellation of errors and allow selectivity to be predicted more accurately than affinity. Here, we assess the accuracy with which selectivity can be predicted in the context of small-molecule kinase inhibitors, considering the very similar binding sites of human kinases CDK2 and CDK9 as well as another series of ligands attempting to achieve selectivity between the more distantly related kinases CDK2 and ERK2. Using a Bayesian analysis approach, we separate systematic from statistical errors and quantify the correlation in systematic errors between selectivity targets. We find that, in the CDK2/CDK9 case, a high correlation in systematic errors suggests that free-energy calculations can have significant impact in aiding chemists in achieving selectivity, while in more distantly related kinases (CDK2/ERK2), the correlation in systematic error suggests that fortuitous cancellation may even occur between systems that are not as closely related. In both cases, the correlation in systematic error suggests that longer simulations are beneficial to properly balance statistical error with systematic error to take full advantage of the increase in apparent free-energy calculation accuracy in selectivity prediction.
Keyword:
FREE-ENERGY PERTURBATION
KRAS-MUTANT LUNG
PROTEIN
INHIBITOR
DISCOVERY
CANCER
RESISTANCE
TYROSINE
GLEEVEC
EGFR
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
5.3
论文数:
9.1K
被引数:
4.0W
机构
引用论文
.png){kind=icon}
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and ProteinsOPLS3: 广泛覆盖药物小分子和蛋白质的力场
PREAI
分享收藏Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?前所未有的大规模激酶抑制剂集能够准确预测复合激酶活性: 一种通过设计实现选择性混杂的方法？OAAI
OAAI分享收藏
查看更多内容